Balyasny Asset Management’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
Other funds holding INSM
BBA
DGM
OAG
Balyasny Asset Management's INSM Position: Q2 2026 in Review
Balyasny Asset Management increased its Insmed (INSM) stake by 498% in Q2 2026, buying an estimated $134M and bringing the position to 1,326,430 shares worth $141M. The position accounts for 0.18% of the portfolio, ranked #128.
Balyasny Asset Management first reported a position in INSM in Q3 2018 and has held it in 16 quarters since. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.
- Balyasny Asset Management held 1,326,430 shares of Insmed worth $141M as of Q2 2026.
- Balyasny Asset Management bought 1,104,723 Insmed shares in Q2 2026, an estimated $134M.
- Insmed made up 0.18% of Balyasny Asset Management's portfolio in Q2 2026, its #128 holding.
- Balyasny Asset Management first reported a position in Insmed in Q3 2018 and has held it in 16 quarters since.
- 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.